Reliability of Measuring Blood Pressure With a Smartwatch
NCT ID: NCT05401435
Last Updated: 2022-06-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
15 participants
INTERVENTIONAL
2022-05-04
2022-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-invasive Blood Pressure Measurement Using Samsung Smartwatch
NCT05302193
Experimental Validation of the Long-term Accuracy of Blood Pressure Measurement Using a Smartwatch
NCT06098092
Smartwatch ABPM vs. Conventional ABPM
NCT04553861
Validation of a Smartwatch for Blood Pressure Monitoring
NCT06627920
Effect of Smart Phone Based Telemonitoring on Blood Pressure Among Hypertensive Patients in Primary Care
NCT02046993
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Blood pressure and heart rate measurement
Resting blood pressure and heart rate measurement regularly one value in the morning and evening for 28 days. The volunteer measures the parameters simultaneously on both devices (smartwatch and digital tonometer). In total, each participant will undergo this measurement 56 times.
Resting measurement of blood pressure and heart rate
Simultaneous blood pressure and heart rate measurement every morning and evening during the duration of the experiment (28 days).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Resting measurement of blood pressure and heart rate
Simultaneous blood pressure and heart rate measurement every morning and evening during the duration of the experiment (28 days).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* pregnancy
* severe cardiovascular conditions
* severe asthma or other severe respiratory conditions
* diabetes
* hypotension or hypertension
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Czech Technical University in Prague
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Barbora Nezpevakova, Bc.
Role: PRINCIPAL_INVESTIGATOR
Czech Technical University in Prague
Veronika Rafl Huttova, MSc
Role: PRINCIPAL_INVESTIGATOR
Czech Technical University in Prague
Martin Rozanek, PhD
Role: PRINCIPAL_INVESTIGATOR
Czech Technical University in Prague
Jakub Rafl, PhD
Role: PRINCIPAL_INVESTIGATOR
Czech Technical University in Prague
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Biomedical Engineering, Czech Technical University in Prague
Kladno, , Czechia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
van Helmond N, Freeman CG, Hahnen C, Haldar N, Hamati JN, Bard DM, Murali V, Merli GJ, Joseph JI. The accuracy of blood pressure measurement by a smartwatch and a portable health device. Hosp Pract (1995). 2019 Oct;47(4):211-215. doi: 10.1080/21548331.2019.1656991. Epub 2019 Aug 26.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIBPsmartwatch22
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.